Robert G. Conway's Insider Trades & SAST Disclosures

Robert G. Conway's most recent trade in Agile Therapeutics Inc was a trade of 13,500 Common Stock done . Disclosure was reported to the exchange on June 28, 2023.

Share

Note

This is a custom search result for pattern Robert G. Conway.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Agile Therapeutics Inc Results 52 week low	Robert G. Conway	Chief Supply Chain Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Jun 2023	13,500	13,529 (0%)	0%		0	Common Stock
Agile Therapeutics Inc Results 52 week low	Robert G. Conway	Chief Supply Chain Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Jun 2023	4,500	4,500	-		-	Employee Stock Option (Right to Buy)
Agile Therapeutics Inc Results 52 week low	Robert G. Conway	Chief Supply Chain Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Nov 2022	10,000	10,000	-		-	Employee Stock Option (Right to Buy)
Agile Therapeutics Inc Results 52 week low	Robert G. Conway	Chief Supply Chain Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	19 Jan 2022	225,000	225,000	-		-	Employee Stock Option (Right to Buy)
Agile Therapeutics Inc Results 52 week low	Robert G. Conway	SVP Chief Supply Chain Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Jan 2021	173,160	173,160	-		-	Employee Stock Option (Right to Buy)
Agile Therapeutics Inc Results 52 week low	Robert G. Conway	SVP Chief Supply Chain Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Jan 2021	35,461	58,357 (0%)	0%		0	Common Stock
Agile Therapeutics Inc Results 52 week low	Robert G. Conway	SVP Chief Supply Chain Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.76 per share.	19 Nov 2020	4,149	22,896 (0%)	0%	1.8	7,302	Common Stock
Agile Therapeutics Inc Results 52 week low	Robert G. Conway	SVP Chief Supply Chain Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	19 Nov 2020	4,149	0	-		-	Employee Stock Option (Right to Buy)

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades